vTv Therapeutics Inc (VTVT)
29.01
+0.80
(+2.84%)
USD |
NASDAQ |
May 21, 13:59
vTv Therapeutics Cash from Operations (Quarterly): -7.335M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -7.335M |
| December 31, 2023 | -2.914M |
| September 30, 2023 | -4.834M |
| June 30, 2023 | -6.167M |
| March 31, 2023 | -5.166M |
| December 31, 2022 | -6.88M |
| September 30, 2022 | -8.827M |
| June 30, 2022 | 0.706M |
| March 31, 2022 | -1.021M |
| December 31, 2021 | -6.417M |
| September 30, 2021 | -3.594M |
| June 30, 2021 | -3.998M |
| March 31, 2021 | -5.299M |
| December 31, 2020 | -2.212M |
| September 30, 2020 | -5.434M |
| June 30, 2020 | -4.794M |
| March 31, 2020 | -5.56M |
| December 31, 2019 | -5.876M |
| September 30, 2019 | -6.195M |
| June 30, 2019 | -5.497M |
| March 31, 2019 | -5.45M |
| Date | Value |
|---|---|
| December 31, 2018 | -5.869M |
| September 30, 2018 | -6.26M |
| June 30, 2018 | -9.33M |
| March 31, 2018 | -5.397M |
| December 31, 2017 | -6.331M |
| September 30, 2017 | -11.78M |
| June 30, 2017 | -12.64M |
| March 31, 2017 | -13.82M |
| December 31, 2016 | -11.43M |
| September 30, 2016 | -12.73M |
| June 30, 2016 | -11.55M |
| March 31, 2016 | -12.50M |
| December 31, 2015 | -8.97M |
| September 30, 2015 | -9.822M |
| June 30, 2015 | -8.788M |
| March 31, 2015 | -9.366M |
| December 31, 2014 | -6.979M |
| September 30, 2014 | -5.558M |
| June 30, 2014 | -7.246M |
| March 31, 2014 | -11.00M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-8.827M
Minimum
Sep 2022
0.706M
Maximum
Jun 2022
-4.866M
Average
-5.366M
Median
Cash from Operations (Quarterly) Benchmarks
| Altimmune Inc | -16.36M |
| Palatin Technologies Inc | -8.607M |
| Oragenics Inc | -3.064M |
| Viking Therapeutics Inc | -6.134M |
| G1 Therapeutics Inc | -8.898M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 50.14M |
| Free Cash Flow | -21.25M |
| Free Cash Flow Per Share (Quarterly) | -1.771 |
| Free Cash Flow to Equity (Quarterly) | -7.144M |
| Free Cash Flow to Firm (Quarterly) | -7.335M |
| Free Cash Flow Yield | -28.05% |